Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DOPA PET in Congenital Hyperinsulinism
NCT00674440Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Dec 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorodopa in congenital hyperinsulinism (HI), sponsored by Children's Hospital of Philadelphia. Started Dec 2004; status: completed.
02
Drugs
fluorodopa
03
Conditions
congenital hyperinsulinism (HI)
Beyond the preview
Go deeper on NCT00674440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674440.